投稿咨詢
This journal publishes scholarly reviews and experimental papers that address the state of the art in the management of allergic and immunologic diseases and in particular place newly available data into perspective. Each issue of the journal is devoted to a single theme of critical importance to allergists and immunologists, with the goal of providing a comprehensive treatment of the subject that will benefit a wide readership. Readers will find the journal of value in elucidating the impact of novel data on clinical management against the background of advances such as the development of standardized protocols for allergy skin testing and challenge procedures and improved understanding of cell biology. The ultimate objective is to help improve the care and management of patients with immune-mediated disease.
《Clinical Reviews In Allergy & Immunology》是一本由HUMANA PRESS INC出版商出版的專業醫學期刊，該刊創刊于1983年，刊期Bimonthly，該刊已被國際權威數據庫SCI、SCIE收錄。在中科院最新升級版分區表中，該刊分區信息為大類學科：醫學 2區，小類學科：過敏 2區；免疫學 2區；在JCR（Journal Citation Reports）分區等級為Q1。該刊發文范圍涵蓋過敏等領域，旨在及時、準確、全面地報道國內外過敏工作者在該領域取得的最新研究成果、工作進展及學術動態、技術革新等，促進學術交流，鼓勵學術創新。2021年影響因子為10.817，平均審稿速度較慢,6-12周。
| 大類學科 | 分區 | 小類學科 | 分區 | Top期刊 | 綜述期刊 |
| 醫學 | 2區 | ALLERGY 過敏 IMMUNOLOGY 免疫學 | 2區 2區 | 否 | 是 |
| JCR分區等級 | JCR所屬學科 | 分區 | 影響因子 |
| Q1 | IMMUNOLOGY | Q1 | 10.817 |
| ALLERGY | Q1 |
| 影響因子 | h-index | Gold OA文章占比 | 研究類文章占比 | OA開放訪問 | 平均審稿速度 |
| 10.817 | 67 | 16.06% | 75.00% | 未開放 | 較慢,6-12周 |
課題、SCI/EI/SSCI怎么寫？